🔗 Read the article: https://bit.ly/4eyNFjq
🎟️ Register for iDR26: remedi4all.org/iDR26
🔗 Read the article: https://bit.ly/4eyNFjq
🎟️ Register for iDR26: remedi4all.org/iDR26
LifeArc is a not-for-profit medical research organisation transforming lives through pioneering research in rare diseases and drug‑resistant infections.s.
🔗 More on LifeArc: https://loom.ly/pzFCQ1o
🎟️ Register for #iDR26: https://loom.ly/9dw7qdk
LifeArc is a not-for-profit medical research organisation transforming lives through pioneering research in rare diseases and drug‑resistant infections.s.
🔗 More on LifeArc: https://loom.ly/pzFCQ1o
🎟️ Register for #iDR26: https://loom.ly/9dw7qdk
Join us on 12–13 May 2026 for iDR26 – Navigating the future, bringing the global drug repurposing community together for two days of discussion, collaboration & patient-focused insight.
🎟️ Explore the programme and register: https://loom.ly/RA5Yss4
Join us on 12–13 May 2026 for iDR26 – Navigating the future, bringing the global drug repurposing community together for two days of discussion, collaboration & patient-focused insight.
🎟️ Explore the programme and register: https://loom.ly/RA5Yss4
Thank you for joining us, for your active engagement, and for your valuable contributions. Special thanks to all speakers, moderators, panellists, sponsors, and partners who helped make #iDR26 possible.
📅 12–13 May 2026, Brussels
🔗 Learn more and register here: https://loom.ly/9dw7qdk
📅 12–13 May 2026, Brussels
🔗 Learn more and register here: https://loom.ly/9dw7qdk
On 12–13 May 2026, the International Drug Repurposing Conference by @remedi4all.bsky.social and #Beacon_for_Rare_Diseases returns with #iDR26. 💊
Don't miss the opportunity to take part in this unique conference programme! 👉 Full agenda here: https://loom.ly/RA5Yss4
On 12–13 May 2026, the International Drug Repurposing Conference by @remedi4all.bsky.social and #Beacon_for_Rare_Diseases returns with #iDR26. 💊
Next stop: #iDR26, 12–13 May 2026 in Brussels, co-organised by REMEDi4ALL.
👉 More at: https://loom.ly/KUXmq1U
Next stop: #iDR26, 12–13 May 2026 in Brussels, co-organised by REMEDi4ALL.
👉 More at: https://loom.ly/KUXmq1U
Researchers analysed 5000+ repurposed compounds to build an ML model predicting drug‑induced phospholipidosis helping reduce false positives in early drug screening.
📚Read the publication: https://loom.ly/dhGyf_M
🎟️More at #iDR26: https://loom.ly/9dw7qdk
Researchers analysed 5000+ repurposed compounds to build an ML model predicting drug‑induced phospholipidosis helping reduce false positives in early drug screening.
📚Read the publication: https://loom.ly/dhGyf_M
🎟️More at #iDR26: https://loom.ly/9dw7qdk
Don't miss the opportunity to take part in this unique conference programme! 👉 Full agenda here: https://loom.ly/RA5Yss4
Don't miss the opportunity to take part in this unique conference programme! 👉 Full agenda here: https://loom.ly/RA5Yss4
New REMEDi4ALL work in Health Policy OPEN uses multi‑stakeholder input to prioritise barriers and inform actionable reforms.
Join #iDR26 to learn more🎟️: https://loom.ly/gh97s9k
REMEDi4ALL summary here➡️: https://loom.ly/IdIBEak
New REMEDi4ALL work in Health Policy OPEN uses multi‑stakeholder input to prioritise barriers and inform actionable reforms.
Join #iDR26 to learn more🎟️: https://loom.ly/gh97s9k
REMEDi4ALL summary here➡️: https://loom.ly/IdIBEak
You can take part by submitting an abstract for the Poster Session or by applying for a Lightning Talk. Read more and find the deadlines below!
➡️ Apply here: https://loom.ly/XvNoRTM
You can take part by submitting an abstract for the Poster Session or by applying for a Lightning Talk. Read more and find the deadlines below!
➡️ Apply here: https://loom.ly/XvNoRTM
Read our highlights and takeaways here: https://loom.ly/IGWmuZQ
Read our highlights and takeaways here: https://loom.ly/IGWmuZQ
@elstorreele.bsky.social at today’s #iDR26
“We need to rebalance public need with the private sector and commercial interest.”
@elstorreele.bsky.social at today’s #iDR26
“We need to rebalance public need with the private sector and commercial interest.”
See you tomorrow for more track and plenary sessions!
👉 Check out some of the highlights from today's session below and find full agenda here: https://loom.ly/RA5Yss4
See you tomorrow for more track and plenary sessions!
👉 Check out some of the highlights from today's session below and find full agenda here: https://loom.ly/RA5Yss4
Our sister project @remedi4all.bsky.social will host its annual conference on 12-13 May '26 in Brussels. Find out more about #iDR26 👉 remedi4all.org/2026-interna...
We look forward to joining for the advancement of drug repurposing in Europe 💊
Our sister project @remedi4all.bsky.social will host its annual conference on 12-13 May '26 in Brussels. Find out more about #iDR26 👉 remedi4all.org/2026-interna...
We look forward to joining for the advancement of drug repurposing in Europe 💊
Discussions explored innovative #DrugRepurposing funding models, policy & regulatory conditions, and new tools supporting collaboration!
🔗Learn more: https://loom.ly/CxpCqYc
Discussions explored innovative #DrugRepurposing funding models, policy & regulatory conditions, and new tools supporting collaboration!
🔗Learn more: https://loom.ly/CxpCqYc
We’re thrilled to announce more confirmed speakers, bringing diverse perspectives from across the drug repurposing ecosystem.
📅 12–13 May, Brussels
🔗 See the programme and register: https://loom.ly/9dw7qdk
We’re thrilled to announce more confirmed speakers, bringing diverse perspectives from across the drug repurposing ecosystem.
📅 12–13 May, Brussels
🔗 See the programme and register: https://loom.ly/9dw7qdk
This #iDR26 session will highlight key innovations in the Spanish drug development network, from patient engagement and academic research support to regulatory and reimbursement programs and incentives.
👉 https://loom.ly/9dw7qdk
This #iDR26 session will highlight key innovations in the Spanish drug development network, from patient engagement and academic research support to regulatory and reimbursement programs and incentives.
👉 https://loom.ly/9dw7qdk
Join the leading international conference on drug repurposing and engage with global experts shaping the future of patient-centric medicines.
🎟️ Get your early bird ticket here: https://loom.ly/9dw7qdk
Join the leading international conference on drug repurposing and engage with global experts shaping the future of patient-centric medicines.
🎟️ Get your early bird ticket here: https://loom.ly/9dw7qdk
👉 Discover the full agenda here: https://loom.ly/RA5Yss4
👉 Discover the full agenda here: https://loom.ly/RA5Yss4
@natrevdrugdiscov.nature.com after nearly 2 years of discussions, collaboration & collective efforts across the #DrugRepurposing community
Looking forward to seeing you at #iDR26 next week in Brussels!🤗
💫 Contenta d’haver-hi contribuït
#Teamit
🔗 Read the article: https://bit.ly/4eyNFjq
🎟️ Register for iDR26: remedi4all.org/iDR26
@natrevdrugdiscov.nature.com after nearly 2 years of discussions, collaboration & collective efforts across the #DrugRepurposing community
Looking forward to seeing you at #iDR26 next week in Brussels!🤗
💫 Contenta d’haver-hi contribuït
#Teamit
Showcase your work, stories, and experiences to an international audience of professionals and thought leaders in the drug repurposing field.
🔗 Submit your abstract by 16 January: https://loom.ly/FJ0Clno
Showcase your work, stories, and experiences to an international audience of professionals and thought leaders in the drug repurposing field.
🔗 Submit your abstract by 16 January: https://loom.ly/FJ0Clno
Takeaways:✅Collaboration is critical ✅AI is accelerating drug discovery Early regulatory insight matters.
Get in touch: bit.ly/3GcxCWz
Takeaways:✅Collaboration is critical ✅AI is accelerating drug discovery Early regulatory insight matters.
Get in touch: bit.ly/3GcxCWz
We’re excited to welcome a new wave of experts joining the conference to explore what’s next in drug repurposing—from rare diseases and AI-driven discovery to policy, funding, and community-led success stories.
📅 12–13 May, Brussels
🔗https://loom.ly/9dw7qdk
We’re excited to welcome a new wave of experts joining the conference to explore what’s next in drug repurposing—from rare diseases and AI-driven discovery to policy, funding, and community-led success stories.
📅 12–13 May, Brussels
🔗https://loom.ly/9dw7qdk